Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study

Thierry André, Hélène Blons, May Mabro, Benoist Chibaudel, Jean‐Baptiste Bachet, C. Tournigand, Mohammed Bennamoun, Pascal Artru, Suzanne Nguyen, C. Ebenezer, Nasredine Aïssat, Anne Cayre, Frédérique Penault‐Llorca, Pierre Laurent‐Puig, Aimery de GramontAnnals 2012 · DOI

BibTeX
@article{andre2012panitumumab,
  author = {Thierry André and Hélène Blons and May Mabro and Benoist Chibaudel and Jean‐Baptiste Bachet and C. Tournigand and Mohammed Bennamoun and Pascal Artru and Suzanne Nguyen and C. Ebenezer and Nasredine Aïssat and Anne Cayre and Frédérique Penault‐Llorca and Pierre Laurent‐Puig and Aimery de Gramont},
  title = {{Panitumumab combined with irinotecan for patients with KRAS wild-type metastatic colorectal cancer refractory to standard chemotherapy: a GERCOR efficacy, tolerance, and translational molecular study}},
  journal = {Annals},
  year = {2012},
  doi = {10.1093/annonc/mds465},
}

Loading related content...

Figure